Incyte Pharmaceuticals Inc., Oxford Gene Technology Ltd. deal

The companies cross-licensed their respective microarray and gene expression technologies (see BioCentury, Nov. 15). INCY received a co-exclusive license to Oxford Gene patents to develop large gene e...